top of page
News
News
Services do NOT include
Fill and finish.
Possible Output
A GMP documented and QA released antigen to be used in vaccine formulation.
Sample Requirements - input of users
Aminoacid sequence and requirements for antigen characteristics, (folding, size, aggregation).
Lead Scientist
Charlotte Green Jensen
Description of service
GMP production of recombinant vaccine candidates for clinical trials phase I/II. SSI offers Manufacture of GMP master/working cell banks and manufacture of clinical-grade vaccine candidate (drug substance).
Timeline
12 months
Provider
Statens Serum Institut (SSI), Vaccine Development Department, GMP Pilot plant facility, Denmark
GMP production services of recombinant vaccine candidates for clinical trials phase I/II
Paid Service
bottom of page